MedPath

SINGAPORE HEALTH SERVICES

πŸ‡ΈπŸ‡¬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
2 (100.0%)

Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.

Not Applicable
Recruiting
Conditions
Metabolic Syndrome
Severe Obesity
Reflux, Gastroesophageal
Bariatric Surgery
First Posted Date
2025-01-03
Last Posted Date
2025-02-14
Lead Sponsor
Singapore Health Services
Target Recruit Count
500
Registration Number
NCT06757296
Locations
πŸ‡ΈπŸ‡¬

Changi General Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Sengkang General Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Singapore General Hospital, Singapore, Singapore

Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes

Completed
Conditions
COVID-19
First Posted Date
2024-02-29
Last Posted Date
2024-02-29
Lead Sponsor
Singapore Health Services
Target Recruit Count
11000
Registration Number
NCT06285838
Locations
πŸ‡ΈπŸ‡¬

Singapore Health Services Pte ltd, Singapore, Singapore

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.